BEAM
Beam Therapeutics Inc.
$30.84
-0.05 (-0.16%)
At close · Jul 15
Market Cap
$2.92B
Shares
102,879,214
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$30.84
Open$30.54
Day$30.15–31.30
52W$15.60–38.26
Avg vol 30d2.4M
Short int22.9M · 22.2% float · 8.4d
Short vol79%
Last earningsFeb 24, 2026
DataFeb 2020–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Jun 15, 2027
Est · unconfirmed
· in 48 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
−3%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
67%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−1%
trailing
YTD return
+11%
this year
Relative strength
−11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $32 › 200d $28 — 50d above 200d
Institutional flow
Distributing
16 of 253 funds reported for Jun 30 · net -45.5K sh shares · +5 new
Insider flow
Distributing
Net -$10.0M over 90 days · 100% sells
Short interest
Falling
22.24% of float · ▼ -19.2% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
253 holders — near 3-yr high, broad support
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
+33%
Y/Y
EPS growth
+82%
Y/Y
Free cash flow
$-360.0M
Balance sheet
$294.9M
net cash
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−38%
past year
ATR
8.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
−3%
Neutral
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
67%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $32 › 200d $28 — 50d above 200d
Institutional flow
Distributing
16 of 253 funds reported for Jun 30 · net -45.5K sh shares · +5 new
Insider flow
Distributing
Net -$10.0M over 90 days · 100% sells
Short interest
Falling
22.24% of float · ▼ -19.2% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
253 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $16
Now $31 · 67%
52-wk high $38
vs 200-day avg +10%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, cash equivalents and marketable securities | 1.2B | Q1 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BEAM
this stock
Beam Therapeutics Inc.
|
$2.92B | +11.3% | +33.3% | — | 22.2% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +2.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +5.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -13.8% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.6% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BEAM | -16.4% | -0.9% | -0.9% | -10.1% | +11.3% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -17.6% | -0.7% | -11.0% | -11.2% | +0.6% |
Key facts
CIK
1745999
CUSIP
07373V105
13F (30d)
16 filings
14 filers
Visit website
Investor relations